Not having FDA and ePA all these years was the reason they couldn't sell any in the US hospitals. Just read the news releases. https://stockhouse.com/news/press-releases/2018/01/18/medizone-determines-regulatory-pathway-for-the-asepticsure-system-a That problem isn't going away for the guy who bought the technology from mzei. Not having any tech now or a phone number or employees are 3 more reasons mzei is dead. The week before last it traded 46,000 shares. It's going to be hard for bag holders to bear when the gamblers stop trading. https://www.stockwatch.com/Quote/Detail?U:MZEIQ&snapshot=SX